IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

venBio Partners LLC

Q4 2025 Holdings

Filed 2026-02-17 | 6 holdings | $216.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pharvaris N V(PHVS)COMN69605108$128.7M4,639,30459.5%
Alumis Inc(ALMS)COM022307102$45.1M4,619,80320.8%
Harmony Biosciences Hldgs in(HRMY)COM413197104$18.3M489,1948.5%
ALX Oncology Hldgs Inc(ALXO)COM00166B105$11.0M9,699,9255.1%
Lyell Immunopharma Inc(LYEL)COM NEW55083R203$10.4M337,6974.8%
Artiva Biotherapeutics Inc(ARTV)COM04317A107$2.8M648,5071.3%